APA (7th ed.) Citation

Gaspari, T., Welungoda, I., Widdop, R. E., Simpson, R. W., & Dear, A. E. (2013). The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse model. Diabetes & vascular disease research, 10(4), 353-360. https://doi.org/10.1177/1479164113481817

Chicago Style (17th ed.) Citation

Gaspari, Tracey, Iresha Welungoda, Robert E. Widdop, Richard W. Simpson, and Anthony E. Dear. "The GLP-1 Receptor Agonist Liraglutide Inhibits Progression of Vascular Disease via Effects on Atherogenesis, Plaque Stability and Endothelial Function in an ApoE−/− Mouse Model." Diabetes & Vascular Disease Research 10, no. 4 (2013): 353-360. https://doi.org/10.1177/1479164113481817.

MLA (9th ed.) Citation

Gaspari, Tracey, et al. "The GLP-1 Receptor Agonist Liraglutide Inhibits Progression of Vascular Disease via Effects on Atherogenesis, Plaque Stability and Endothelial Function in an ApoE−/− Mouse Model." Diabetes & Vascular Disease Research, vol. 10, no. 4, 2013, pp. 353-360, https://doi.org/10.1177/1479164113481817.